NCT00085813 - Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

Non-Small-Cell Lung Cancer

Interventions

DRUG

Ispinesib

Trial Locations (11)

GSK Investigational Site, Brussels

GSK Investigational Site, Edegem

GSK Investigational Site, Leuven

GSK Investigational Site, Rochester

GSK Investigational Site, Philadelphia

GSK Investigational Site, Greensboro

GSK Investigational Site, Jacksonville

GSK Investigational Site, Memphis

GSK Investigational Site, Rochester

GSK Investigational Site, Scottsdale

GSK Investigational Site, Sutton